Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 281-286

  Strome, Scott E ^a   Kasperbauer, Jan L ^a   Alejandro, Danielle ^b   Voss, Stephen ^b   Chen, Lieping ^b   Salomao, Diva ^c   Kawakami, Koji ^d   Puri, Raj K ^d   Maki, Richard A ^e  

^a Departments of Otolaryngology   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c Departments of Pathology   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; HYBRID PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PSEUDOMONAS EXOTOXIN; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG RECEPTOR BINDING; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; KAPOSI SARCOMA; KIDNEY CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYTOTOXINS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOTOXINS; INJECTIONS, INTRALESIONAL; INTERLEUKIN-4; MALE; MICE; MICE, NUDE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-4; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036152437     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Current status and future directions
2. Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: A phase II feasibility study
3. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means?
4. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells
5. Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ
6. Structure and function of interleukin-4 and its receptor
7. A circularly permuted recombinant interleukin 4 toxin with increased activity
8. Increased antitumor activity of a circularly permuted IL-4 -toxin in mice with IL-4 receptor bearing human carcinoma
9. An improved circularly permutated interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells: Introduction of γ common chain in RCC cells does not improve sensitivity
10. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi’s sarcoma tumors in xenograft model
11. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy
12. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo
13. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma
14. Expression of high affinity IL-4 receptors on murine sarcoma cells and receptor mediated cytotoxicity of tumor cells to chimeric protein between IL-4 and Pseudomonas exotoxin
15. Preclinical development of a recombinant toxin containing circularly permuted interleukin-4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma
16. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin-4
17. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo
18. Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol
19. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma